Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2013-02-22 | Reverse | 5:7 |
Kilroy Realty Corporation is a leading West Coast REIT specializing in sustainable office, life science, and mixed-use spaces, with a strong presence in major California markets and a focus on innovation, tenant retention, and environmentally resp...

A $1 billion, multi-building life science campus in South San Francisco, serving as a key portfolio asset, caters to growing tech and life sciences tenants with high-quality, modern real estate.
In a significant vote of confidence for the West Coast office market, New York-based hedge fund D1 Capital Partners disclosed a substantial investment in Kilroy Realty, acquiring nearly 6.6 million shares in the third quarter of 2025. The stake, valued at $358.4 million, was seen as a major contrarian bet and garnered significant attention from investors and analysts.
In 2025, Kilroy Realty Corporation strategically transitioned its newly completed, $1.0 billion Kilroy Oyster Point (KOP) Phase 2 project from a traditional development into a curated life science ecosystem. This was actioned through targeted leasing to a mix of established biotech firms and, most notably, a partnership with life science incubator MBC BioLabs, a deliberate move to foster innovation and create a pipeline of future tenants for the massive 872,000-square-foot campus.
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
REXR | $37.01 | COMPARE |
VNO | $33.80 | COMPARE |
KRG | $24.13 | COMPARE |
SBRA | $18.96 | COMPARE |
CUZ | $27.75 | COMPARE |
HHH | $71.43 | COMPARE |
EPR | $54.38 | COMPARE |
CDP | $33.48 | COMPARE |